Omri Amirav Drory
General Partner at NFX
Menlo Park, California
Overview
Work Experience
Board Member
2024 - Current
Board Member
2024
TwoStep Therapeutics is developing novel tumor-targeting therapeutics for solid tumors.
Raised $6,500,000.00 from Alexandria Venture Investments, 2048 Ventures, NFX and GC&H Investments.
Board Member
2023
ZipBio develops next-gen gene therapies using machine learning, protein engineering, and molecular materials.
Raised $4,000,000.00 from MoreVC and NFX.
Board Member
2022
Centivax is a healthcare-based agency that provides biotechnology, pharmaceutical, medical device manufacturing, and therapeutic services.
Raised $14,200,000.00 from NFX and Global Health Investment Corporation.
Founder & CEO
2022
Renewal - Renewing human health
Board Member
2021
Talus Bio is a drug discovery biotech company that develops drugs targeting undruggable transcription factors using AI.
Raised $27,781,502.00 from NFX, FundersClub, BoxOne Ventures, Two Bear Capital, Y Combinator Continuity Fund, Rolling Bay Ventures and WRF Capital.
Board Member
2021
Mana.bio is an AI based drug delivery startup, focusing on gene therapy including DNA and RNA-based therapeutics, and vaccines.
Raised $29,500,000.00 from Technion - Israel Institute of Technology, NFX, LionBird, Andreessen Horowitz, Base4 Capital and NFX.
Board Member
2021
La Jolla Labs is a therapeutics company that delivers high-throughput screening technology for drug discovery.
Board Member
2021
Board Member
2021
Pepper Bio is a trans-omics company that helps researchers and drug developers discover new drugs.
Raised $6,500,000.00 from big_bets, Tensility Venture Partners, NFX, Mana Ventures, VSC Ventures, Merck Digital Sciences Studio, Silverton Partners and Reinforced Ventures.
Education
Postdoctoral
2007 - 2011
Doctor of Philosophy (Ph.D.)
2003 - 2007
Bachelor of Science - BS
2001 - 2003